CORONA Main Coronavirus thread

Zoner said:

He may be in the dark, but we're not. He probably isn't either, but they haven't told him WHY they pulled his book and that is wrong and I'm going to send a note to Amazon and register my complaint and threaten to stop my purchases there.

Click to expand...

There is a naivette to Geert. He still blames all of the vaccine issues on stupidity of the policy makers and pharmaceuticals, not on malice aforethought, or if that's too much to expect (that he'd buy into 'conspiracy theories'), on greed of pharma or control and power issues of world govts, which is what most of the other doctors in the movement blame it on. He just believes they don't know the science as well as he does. He has his biases, he worked with these people for decades. So it's understandable he sees them in a positive light. Maybe this will finally begin to wake him up.

In the meantime, obviously Geert has hit a nerve. The question is why? What makes Geert's anti-vaxx book more dangerous to TPTB than the following books - all available for sale on Amazon:


RJK Jr - The Real Anthony Fauci

Naomi Wolf - The Bodies of Others

Andrew Huff - The Truth About Wuhan

Mercola - The Truth About Covid

Dr.McCullough - THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex

Robert Malone - Lies My Gov't Told Me: And the Better Future Coming

Paul Alexander - Presidential Takedown: How Anthony Fauci, the CDC, NIH, and the WHO Conspired to Overthrow President Trump

Mattias Desmet - The Psychology of Totalitarianism

Judy Mikovits - Ending Plague: A Scholar's Obligation in an Age of Corruption

This author/book I never even heard of, AMAZON listed it as a suggestion multiple times when I searched out the other titles:

Collen Huber - Neither Safe Nor Effective: The Evidence Against the COVID Vaccines

~~~~~~~~~

As I mentioned the other day, I couldn't find Geert's book the week it was going to be published on Amazon in the USA, it only came up in Germany. It's still saying what it said then, not available in paperbook but available for kindle in English - so Germans (who are the majority users of the site) won't download it, and how many Americans/Brits know to check Germany's Amazon page to get it there?
btw it's 19.00Euro which as of this posting equals $20.31 USD. I don't use kindle but I think my ipad has the app and may download it just to support Geert and his effort...

Heliobas Disciple said:

There is a naivette to Geert. He still blames all of the vaccine issues on stupidity of the policy makers and pharmaceuticals, not on malice aforethought, or if that's too much to expect (that he'd buy into 'conspiracy theories'), on greed of pharma or control and power issues of world govts, which is what most of the other doctors in the movement blame it on. He just believes they don't know the science as well as he does. He has his biases, he worked with these people for decades. So it's understandable he sees them in a positive light. I was thinking about posting an analysis of that aspect while I was watching the interview he did this week on his book. I may still.. Either way, maybe this will finally begin to wake him up.

In the meantime, obviously Geert has hit a nerve. The question is why? What makes Geert's anti-vaxx book more dangerous to TPTB than the following books - all available for sale on Amazon:


RJK Jr - The Real Anthony Fauci

The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health (Children’s Health Defense): Kennedy Jr., Robert F.: 9781510766808: Amazon.com: Books

The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health (Children’s Health Defense) [Kennedy Jr., Robert F.] on Amazon.com. *FREE* shipping on qualifying offers. The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public...

www.amazon.com

Naomi Wolf - The Bodies of Others

Amazon.com: The Bodies of Others: The New Authoritarians, COVID-19 and The War Against the Human: 9781737478560: Wolf, Naomi: Books

Amazon.com: The Bodies of Others: The New Authoritarians, COVID-19 and The War Against the Human: 9781737478560: Wolf, Naomi: Books

www.amazon.com

Andrew Huff - The Truth About Wuhan

The Truth about Wuhan: How I Uncovered the Biggest Lie in History: Huff, Dr. Andrew G.: 9781510773882: Amazon.com: Books

The Truth about Wuhan: How I Uncovered the Biggest Lie in History [Huff, Dr. Andrew G.] on Amazon.com. *FREE* shipping on qualifying offers. The Truth about Wuhan: How I Uncovered the Biggest Lie in History

www.amazon.com

Mercola - The Truth About Covid

Amazon.com: The Truth About COVID-19: Exposing The Great Reset, Lockdowns, Vaccine Passports, and the New Normal: 9781645020882: Mercola, Doctor Joseph, Cummins, Ronnie, Kennedy Jr., Robert F.: Books

Amazon.com: The Truth About COVID-19: Exposing The Great Reset, Lockdowns, Vaccine Passports, and the New Normal: 9781645020882: Mercola, Doctor Joseph, Cummins, Ronnie, Kennedy Jr., Robert F.: Books

www.amazon.com

Dr.McCullough - THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex

THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex: Leake, John, McCullough MD, Peter A.: 9798986236308: Amazon.com: Books

THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex [Leake, John, McCullough MD, Peter A.] on Amazon.com. *FREE* shipping on qualifying offers. THE COURAGE TO FACE COVID-19: Preventing Hospitalization and Death While Battling the...

www.amazon.com

Robert Malone - Lies My Gov't Told Me: And the Better Future Coming

Lies My Gov't Told Me: And the Better Future Coming (Children’s Health Defense): Malone, Robert W.: 9781510773240: Amazon.com: Books

Lies My Gov't Told Me: And the Better Future Coming (Children’s Health Defense) [Malone, Robert W.] on Amazon.com. *FREE* shipping on qualifying offers. Lies My Gov't Told Me: And the Better Future Coming (Children’s Health Defense)

www.amazon.com

Paul Alexander - Presidential Takedown: How Anthony Fauci, the CDC, NIH, and the WHO Conspired to Overthrow President Trump

Presidential Takedown: How Anthony Fauci, the CDC, NIH, and the WHO Conspired to Overthrow President Trump: Alexander, Dr. Paul Elias, Heckenlively, Kent: 9781510776227: Amazon.com: Books

Presidential Takedown: How Anthony Fauci, the CDC, NIH, and the WHO Conspired to Overthrow President Trump [Alexander, Dr. Paul Elias, Heckenlively, Kent] on Amazon.com. *FREE* shipping on qualifying offers. Presidential Takedown: How Anthony Fauci, the CDC, NIH, and the WHO Conspired to...

www.amazon.com

Mattias Desmet - The Psychology of Totalitarianism

https://www.amazon.com/Psychology-Totalitarianism-Mattias-

Judy Mikovits - Ending Plague: A Scholar's Obligation in an Age of Corruption

Ending Plague: A Scholar's Obligation in an Age of Corruption (Children’s Health Defense): Ruscetti, Dr. Francis W., Mikovits, Judy, Heckenlively, Kent: 9781510764682: Amazon.com: Books

Ending Plague: A Scholar's Obligation in an Age of Corruption (Children’s Health Defense) [Ruscetti, Dr. Francis W., Mikovits, Judy, Heckenlively, Kent] on Amazon.com. *FREE* shipping on qualifying offers. Ending Plague: A Scholar's Obligation in an Age of Corruption (Children’s Health Defense)

www.amazon.com

This author/book I never even heard of, AMAZON listed it as a suggestion multiple times when I searched out the other titles:

Collen Huber - Neither Safe Nor Effective: The Evidence Against the COVID Vaccines

Neither Safe Nor Effective: The Evidence Against the COVID Vaccines: Huber, Dr. Colleen: 9798810783466: Amazon.com: Books

Neither Safe Nor Effective: The Evidence Against the COVID Vaccines [Huber, Dr. Colleen] on Amazon.com. *FREE* shipping on qualifying offers. Neither Safe Nor Effective: The Evidence Against the COVID Vaccines

www.amazon.com

~~~~~~~~~

As I mentioned the other day, I couldn't find Geert's book the week it was going to be published on Amazon in the USA, it only came up in Germany. It's still saying what it said then, not available in paperbook but available for kindle in English - so Germans (who are the majority users of the site) won't download it, and how many Americans/Brits know to check Germany's Amazon page to get it there?
btw it's 19.00Euro which as of this posting equals $20.31 USD. I don't use kindle but I think my ipad has the app and may download it just to support Geert and his effort...

The Inescapable Immune Escape Pandemic (English Edition) eBook : Bossche, DVM PhD, Geert Vanden: Amazon.de: Kindle Store

The Inescapable Immune Escape Pandemic (English Edition) eBook : Bossche, DVM PhD, Geert Vanden: Amazon.de: Kindle Store

www.amazon.de

Click to expand...

Good deep dive on Geert HD. I think you're right. There's a naivete to him. Somebody does not want that book to get purchased.

I did contact Amazon and threatened to stop my purchases. The person said it wasn't Amazon's doing. Amazon don't care. They said it was pulled further up stream. So I don't know. Somebody will sell it in the US. Just need to be patient.
Maybe getting a Kindle version is the way. Then you have it on computer to copy and paste.

Zoner said:

Good deep dive on Geert HD. I think you're right. There's a naivete to him. Somebody does not want that book to get purchased.

I did contact Amazon and threatened to stop my purchases. The person said it wasn't Amazon's doing. Amazon don't care. They said it was pulled further up stream. So I don't know. Somebody will sell it in the US. Just need to be patient.
Maybe getting a Kindle version is the way. Then you have it on computer to copy and paste.

Click to expand...

The argument Ryan Cole had on the stage in the 2nd video I posted last night, which Geert seemed to want to join in on. They were upset the woman brought up nanotechnology and graphene oxide in the shots. My thoughts on this is Geert worked on this for a long time, but I don't think in the last few years. I think (and I don't know if I read this or heard it or if it's my own thinking) that DARPA (and probably the WEF build back better great reset crowd) took over the MRNA project in the last years. So Geert's knowledge on MRNA vaccines is from his days of research with it (which was bad enough if all the ferrets died), not from after the military got its hands on the tech. In his testing days, there was no nanotech or graphen oxide or self assembling chips, etc which is what the woman was talking about in her presentation so he thinks it's all nonsense. He also wants to be listened to by the Bill Gates/GAVI crowd, the WHO, etc. He still considers himself one of them (and that they are good guys), and that they are just misguided on the science and if they'd just listen to him they'd reverse their ways. I think that clouds his judgment from opening up to any of the 'conspiracy' theories about the current shots or the Internet of Things or the take over by world organizations using technology to do it big brother style (which is what the woman was talking about in her presentation, that got him and Ryan all roiled up). So maybe this thing with Amazon will open his eyes a little.

As for why Amazon won't publish it? Of ALL the books out there, this one could be used against them in a court of law, for instance Nuremberg. This one uses their own science to show that they made huge mistakes, even if he believes they were made in good faith. They had warning from him of what could happen and they ignored it. This book is dangerous for them and I am not surprised it's the only one that you won't be able to find on Amazon.... Hopefully though it's a publisher issue and NOT for that reason, we'll have to wait and see...

HD

Heliobas Disciple said:

The argument Ryan Cole had on the stage in the 2nd video I posted last night, which Geert seemed to want to join in on. They were upset the woman brought up nanotechnology and graphene oxide in the shots. My thoughts on this is Geert worked on this for a long time, but I don't think in the last few years. I think (and I don't know if I read this or heard it or if it's my own thinking) that DARPA (and probably the WEF build back better great reset crowd) took over the MRNA project in the last years. So Geert's knowledge on MRNA vaccines is from his days of research with it (which was bad enough if all the ferrets died), not from after the military got its hands on the tech. In his testing days, there was no nanotech or graphen oxide or self assembling chips, etc which is what the woman was talking about in her presentation so he thinks it's all nonsense. He also wants to be listened to by the Bill Gates/GAVI crowd, the WHO, etc. He still considers himself one of them (and that they are good guys), and that they are just misguided on the science and if they'd just listen to him they'd reverse their ways. I think that clouds his judgment from opening up to any of the 'conspiracy' theories about the current shots or the Internet of Things or the take over by world organizations using technology to do it big brother style (which is what the woman was talking about in her presentation, that got him and Ryan all roiled up). So maybe this thing with Amazon will open his eyes a little.

As for why Amazon won't publish it? Of ALL the books out there, this one could be used against them in a court of law, for instance Nuremberg. This one uses their own science to show that they made huge mistakes, even if he believes they were made in good faith. They had warning from him of what could happen and they ignored it. This book is dangerous for them and I am not surprised it's the only one that you won't be able to find on Amazon.... Hopefully though it's a publisher issue and NOT for that reason, we'll have to wait and see...

HD

Click to expand...

This is so good. All of it. Can’t really add to it or take away from it. I don’t think he knows what’s in these vaccines as you say. It’s one thing to speak against bad science but it’s a whole different thing to speak against evil. And when you put bad science and evil together really bad things happen.

It was a man who is reading his book and taking notes and tweeting out what he is finding out.

View: https://twitter.com/tradsperger/status/1627796736939905024?s=46&t=ZRqQHNu18fPFOR1rA_irOw

This just came in my email earlier.

CDC Adds COVID-19 Vaccine To Childhood Immunization Schedule

The CDC updates its recommended vaccine schedule every year. For this first time, it now includes the COVID vaccine.

By Sarah Cottrell Published on February 9, 2023
Share
Tweet
Pin
Email
Pediatrician or nurse vaccinating baby child patient. Covid-19 vaccine.
PHOTO: RUSLANDASHINSKY / GETTY IMAGES
If you're keeping a close eye on what vaccines your child needs, this year, for the first time, you'll now see the COVID-19 vaccine on the recommended list of childhood immunizations. The Centers for Disease Control and Prevention (CDC) has officially added it to the schedule for people of all ages, particularly children. In the fall of 2022, the Advisory Committee on Immunization Practices (ACIP) voted to recommend the CDC add the COVID vaccine. Now it's official. This comes on the heels of President Joe Biden announcing the end of the national COVID emergency declaration on May 11, 2023.


So what else is new for 2023? Ultimately the guidance remains the same. The main difference is the fact that the COVID vaccine is now officially on the schedule to begin at age 6 months—or any time thereafter. As for boosters, the immunization schedule then points to the CDC's guidance on booster dose vaccination. In other words, when a new booster shot comes out, parents should follow the CDC's recommendation for that particular vaccination. That guidance may include factors like the type of vaccine your child had in their initial primary series (Pfizer or Moderna) or when they had their last shot.

Here's what all of this means for kids and families.

How Vaccines Get On The Vaccine Schedule

The schedule of immunizations your child's pediatrician uses to help keep your child healthy is updated annually. The process includes collaboration between the Food and Drug Administration, which licenses all vaccines, and five different governing boards of trusted experts representing different areas of medicine and public health. That includes the CDC and the American Academy of Pediatrics (AAP).


In response to the COVID pandemic, researchers worked at breathtaking speeds to create an effective COVID vaccine. At the time of publishing, more than 81% of Americans have had at least one dose of the vaccine.1 Now that the vaccine is added to the regular immunization schedule, doctors and parents will have more face-to-face opportunities to talk about the benefits of the vaccine.

"This effort reinforces my support of vaccinating all eligible people, including children, against COVID," says Matthew Harris, M.D., a pediatric emergency medicine physician and medical director of the COVID-19 vaccination program at Cohen Children's Medical Center in New Hyde Park, NY. "The American Academy of Pediatrics has come out very strongly in favor of vaccinating all eligible children, regardless of prior history of COVID."

Everything Parents Need to Know About the COVID-19 Vaccines
Will COVID Vaccines Be Mandated by Schools?

Following a vaccination schedule can feel confusing, considering that there are vaccines for 25 different diseases. That said, not all vaccines listed by the CDC are required for kids to enroll in public school.


Parents should note that adding the COVID vaccine to the childhood immunization schedule does not mean it will be mandated for students before enrolling in public schools. Those types of mandates happen solely at the state and local levels. As NBC News pointed out, the CDC added the HPV vaccine to the immunization schedule; however, only a handful of states have required it for students who matriculate in public schools.

Will the COVID-19 Vaccine Be Mandatory for Kids?
"Moving Covid-19 to the recommended immunization schedule does not impact what vaccines are required for school entrance if any," says Nirav Shah, M.D., director of the Maine Center for Disease Control and Prevention, said at the 2022 ACIP meeting where experts voted to add the vaccine to the schedule. "Local control matters. And we honor that the decision around school entrance for vaccines rests where it did before, which is with the state level, the county level, and at the municipal level if it exists at all."


Others agree that the CDC guidelines are unlikely to create COVID vaccine mandates in public education. "I think it is unlikely to ever be a mandate for public schools," says Dr. Harris. "There are a very select group of vaccine-preventable illnesses that pose such a tremendous risk to the population and that most states chose to make those vaccines mandatory."

Dr. Harris says that unless there is a dramatic change in the COVID virus, he does not foresee the vaccine becoming mandated. However, it will be highly encouraged. "My hope is that this recommendation will generate more conversations between vaccine-hesitant parents and their pediatricians, and maybe those conversations will help parents feel at ease as they become more likely to open to vaccination," said Dr. Harris. "COVID, while thought to be benign in most children, has killed over a thousand children in the last three years; it's made hundreds of thousands of children sick.

So I hope this reinvigorates really important family and provider conversations."

Again, vaccine mandates happen at a state and local level, so check your state or local community to learn how they impact you and your family.

Why Is This COVID Vaccine Recommendation Significant?

The updated immunization schedule including the COVID vaccine and boosters will help insurance providers that usually cover the cost of vaccines listed on the CDC-recommended vaccine schedule. This distinction is significant as the federal government is winding down and ending its publicly funded program to offer free COVID vaccines to kids and adults.


During the 2022 ACIP committee vote, members voted to add the COVID vaccine to the Vaccines for Children Program (VFC), a nationalized public health program that offers free vaccines to kids who are eligible for or covered by Medicaid. Adding the COVID vaccine to the VFC will give greater access to uninsured or underinsured children, which will help inevitably boost COVID vaccination rates. While the CDC has added the COVID vaccine to the updated recommended immunization schedule, more work must be done to fully implement it into the VFC.

Vaccine Schedule for Babies and Toddlers: A Cheat Sheet for Parents
Should My Child Get the COVID Vaccine?

The COVID vaccine is safe and available for anyone over the age of 6 months. While the vaccine won't 100% prevent anyone from getting the virus, it lowers the risk of spread and the risk of developing severe disease requiring hospitalization. Still, some parents wonder if their children should get it. For those still on the fence, Dr. Harris points out that the environment where kids spend their days automatically puts them at a higher risk of getting sick.


"Children spend most of the day in a mass setting," Dr. Harris says. "They are in school, they are in camp, they are in social teams, and their ability to participate in other behaviors that minimize risks of infections is limited by the fact that we put them in a condition that they are in amongst lots of other kids who can potentially transmit a virus. I'm a parent of three kids, and they've gotten sick a dozen times because other kids come to school sick."

Some parents worry that giving too many vaccines in a short window can overwhelm a child's natural immune system. However, current data does not support that claim. The AAP notes kids are constantly exposed to germs, called antigens, and in a typical day, might be fighting off between 2,000 and 6,000 antigens. The AAP also says a child fights off under 150 antigens in the entire vaccine schedule combined. In short, kids' immune systems are not overwhelmed by vaccines, and it is safe to add the COVID vaccine to the current recommended vaccine schedule.

Children as young as 6 months can receive either the Pfizer-BioNTech or Moderna vaccines. They recommend that all children receive the vaccine even if they have already been infected with COVID. When it comes to boosters, there are different recommendations depending on whether your child has had the Pfizer or Moderna primary series. You can always check the CDC's website or with your child's pediatrician for the most up-to-date guidance on booster shots.

To learn more about up-to-date data on COVID-19, and the science and safety of vaccines, including the COVID-19 vaccine, visit the CDC website.

Zoner said:

This is so good. All of it. Can’t really add to it or take away from it. I don’t think he knows what’s in these vaccines as you say. It’s one thing to speak against bad science but it’s a whole different thing to speak against evil. And when you put bad science and evil together really bad things happen.

Click to expand...

It's nothing new. It's been called pharmakeia for about 2,000 years.

bracketquant said:

It's nothing new. It's been called pharmakeia for about 2,000 years.

Click to expand...

Pharmakia has been going on a lot longer than 2000 years and the kind of things they’re doing now have never been done before.

I posted about this the other day, this is a more scientific article about it.

(fair use applies)


How COVID-19 Can Impact the Heart: Inflammation, Oxidative Stress and Calcium Changes
By Biophysical Society
February 20, 2023


Hearts from mice infected with COVID-19 have an increased percentage of fibrosis and dilation of the fibers—a common indicator of early cardiomyopathy in mice. Credit: Image courtesy of Andrew Marks

COVID-19 infection can cause changes in calcium channels that can affect how the heart beats, it can also trigger inflammation and oxidative stress in the heart.

Potentially life-threatening heart issues can be caused by COVID-19 infections. Scientific studies suggest that people with COVID-19 are 55% more likely to suffer a major adverse cardiovascular event, including heart attack, stroke, and death, than those without COVID-19. They’re also more likely to have other heart issues, like arrhythmias (abnormal heart rhythms) and myocarditis (inflammation of the heart muscle).

Andrew Marks, a cardiologist and biophysics professor at Columbia University, Steven Reiken, a research scientist in Marks’ lab, and colleagues, have studied some of the changes that occur in the heart that could lead to these problems. Reiken will present their work on Monday, February 20 at the 67th Annual Biophysical Society Meeting in San Diego, California.

In heart tissue from patients who had COVID-19, the team observed increases in oxidative stress (harmful production of unstable molecules) and signals of inflammation, as well as changes in calcium. They also detected adverse changes to a protein called RyR2, which is responsible for regulating the heart’s calcium ion levels. The heart muscle, like all muscle cells, needs calcium ions to contract. The heart’s system for managing calcium ions is essential for the coordinated contractions of the atria and ventricles that pump blood throughout the body. When calcium in the heart becomes dysregulated, it can cause arrhythmias or heart failure.

To study changes to the heart further, they used a mouse model infected with COVID-19. They observed changes to the heart tissue including immune cell infiltration, collagen deposition (indicative of injury), death of heart cells, and blood clots. They also measured changes to the heart proteome—the proteins that are expressed by the heart cells—and found patterns consistent with changes observed to human hearts that were infected with COVID-19, as well as markers of cardiomyopathy, which can make it harder for the heart to pump blood to the body and can lead to heart failure.
“The more awareness you build around particular aspects of a disease, the more likely you are to improve the care of patients. And doctors should be aware of heart changes related to COVID-19 infections and should be looking for them,” Marks said.

Ultimately, “we want to really figure out what’s causing the heart disease and how to fix it,” Marks said. Understanding changes at the molecular level may reveal drug targets that could improve cardiac symptoms related to COVID-19 and help healthcare professionals diagnose and treat these issues more effectively. Additionally, understanding the cardiac complications of COVID-19 can also help public health officials make more informed decisions about how to respond to the COVID-19 pandemic, especially in advising those at higher risk for heart problems.

Zoner said:

It was a man who is reading his book and taking notes and tweeting out what he is finding out.

https://twitter.com/i/web/status/1627796736939905024

View: https://twitter.com/tradsperger/status/1627796736939905024?s=46&t=ZRqQHNu18fPFOR1rA_irOw

Click to expand...

The stream as it reads so far:

Gomez Addams @tradsperger
5:25 PM · Feb 20, 2023

LIVE BOOK REVIEW - THE INESCAPABLE IMMUNE PANDEMIC

In this thread I will be sharing my thoughts on a book I just bought. The book may frighten, it may disappoint, it may enlighten, we'll find out as we go through it.??


Introduction: Geert van den Bossche has been one of the only virologists to correctly warn in advance that vaccinating against SARS2 with Spike based vaccines is a bad idea that would make things worse.

For this reason I went ahead and spent 19 euro to see what he has to say.

I'm particularly interested in figuring out the answer to one question: On what basis does van den Bossche expect that virulence, the evolution of which is notoriously hard to predict for most viruses, will soon increase?

We start out the book with the obligatory thank you notes and a long list of technical terms which I will spare you for now, save one: Steric immune refocusing, which basically means the immune response moves towards focusing on more conserved parts of the Spike protein.

We begin with the preliminary comments. vd Bossche states that trained Cell Based Innate Immunity leads to natural immunity always being more effective than the vaccine-induced immunity, as well as being variant non-specific, in contrast to antibodies from infection or vaccines.

Vd Bossche then defines three severities of disease: Mild, where cell based innate immunity deals with the infection, moderate, where the adaptive response (ie antibodies and T cells) has to jump in to control it, and severe, where the adaptive response fails to eliminate it.

Some more technical lingo, before the Prologue. Bossche states his motive in writing this book: Making it absolutely clear that the disastrous outcome of mass vaccination was predictable and his desire to protect children and future generations.

We now get a summary of Bossche's theory. Notably, he claims the mRNA vaccines induce low affinity anti-Spike antibodies, which then induce Steric Immune Refocusing on other parts of Spike. Once this happens, it irreversibly sidelines the Cell Based Innate Immune system.

Bossche argues the reason virulence has been reduced is due to polyreactive non-neutralizing antibodies: Antibodies that bind to multiple variants, but despite binding to the virus particle can no longer neutralize (render uninfectious) particles of the newer variants.

I've spent ten minutes trying to decipher why Bossche thinks these polyreactive non-neutralizing antibodies reduce virulence and why they will fail, but I'm not up to the task, maybe we'll get a better explanation later on. Instead let's look at who's supposed to escape doomsday.

According to Bossche, a small category of vaccinees did end up with a sufficiently trained cell based innate immune response:

-Healthy vaccinees who got just 1 mRNA shot or no more than 2 non-mRNA shots before a breakthrough infection AND refrained from boosters afterwards.

(fair use applies)


"The Trials Should Have Been Halted": Rate Of 'Serious Adverse Events' Closely Tracks Spike In Post-Vax Disabilities
by Tyler Durden
Monday, Feb 20, 2023 - 01:30 PM

Over the past 18 months, skeptics of mRNA Covid-19 vaccines and those pointing out high rates of adverse reactions have been subject to ostracism, deplatforming, and flawed 'fact checks' to shut down opinions and analysis which conflicted with official narratives.

Now, the data has begun to speak for itself, thanks to people like former Blackrock portfolio manager Ed Dowd, who has devoted the last several years to deep-dive research and analysis of pandemic-related data (in fact, he's written an excellent book on the topic). Dowd, along with partners Carlos Alegria and Yuri Nunes, launched Phinance Technologies - where, aside from traditional macroeconomic analysis, they have produced comprehensive reports on pandemic-related disabilities and excess deaths using official data.

Their latest analysis reveals that the rate of Serious Adverse Events in the mRNA Covid-19 vaccine clinical trials closely tracks a spike in disabilities reported after the vaccine rollout.

In part 3 of our US disabilities analysis we observed that the rise in disability rates post 2/2021 correlates closely with the rollout of the vaccination schedule. When looking at changes in disabilities on a wider time frame (since 2008) we observe that the disability rates rose or fell from month to month but tended to be relatively stable over time. However, as shown in part 1, the change in behaviour since early 2021 is clearly an abnormal occurrence with high level of statistical significance. It happens to be highly correlated to the cumulative Covid-19 vaccine rollout, but we cannot state that the correlation is statistically meaningful as it is based on a cumulative plot with obvious autocorrelation.

In this section we provide further evidence that the most likely cause of the rise in disabilities is the Covid-19 vaccines. For that purpose, we model the expected rise in disabilities due to the vaccination rollout in the general population. We do so by using the rates of Serious Adverse Events (SAEs) obtained by the safety analysis of the mRNA vaccine (Pfizer and Moderna) clinical trials, performed in the Vaccine journal paper we reviewed here, and our analysis in part five.

We can observe that the rate of rise in disabilities is higher than the computed rate of rise in SAEs of special interest, which could be explained in several different ways, or by a combination of factors.

• By the definition of an SAEs of special interest being more extreme than the rate of disabilities reported by the individuals surveyed by the BLS i.e. some disabilities reported by the individuals surveyed by the BLS may be caused by adverse events that are not deemed SAEs of special interest, due to the criteria used to define an SAE being overly restrictive.
• The population of the Civilian Labor Force as a whole may be less healthy (and somehow more vulnerable to vaccine-related disabilities) than the vaccine trial populations, either due to the selection criteria for participation in the trial, or ‘self-selection’ bias.
• Under-reporting of SAEs of special interest in the trial populations.
• Other factors causing excess disabilities in the Civilian Labor Force in a concurrent timeframe to the vaccine rollout.

As Dowd further notes via Twitter;

The rate of estimated SAEs appears to be under-reported relative the recorded rise in disabilities (according to the BLS survey) by about 2.6 times. These results were expected as we had already shown in part 3 of our study the high correlation between the rise in the disability rate since 2/21 with the vaccine rollout. We realise that performing the correlation of cumulative time series is misleading & the R2 should not be taken as an indication of establishing a statistically significant relationship as both time series have autocorrelation."



Bottom line: There were enough safety signals to show that what we are seeing in the BLS data was known during the clinical trials even given their narrow definition of a SAE. The trials should have been halted.

(fair use applies)


Novavax COVID-19 Vaccine Associated With Heart Inflammation: Study
Zachary Stieber
Feb 19 2023

A higher-than-expected number of heart inflammation cases have occurred in people who received Novavax’s COVID-19 vaccine, researchers reported in a new study.

Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found.

Using pre-pandemic rates of heart inflammation in the population, the researchers calculated that the number of postvaccination cases was higher than expected.

Reporting odds ratio values of higher than one indicate a higher-than-expected rate. For myocarditis following the Novavax vaccination, the ratio was 5.2. For pericarditis, it was 24.75. For myopericarditis, or both conditions at once, it was 14.4.

Heart inflammation is a known side effect of the Pfizer and Moderna COVID-19 vaccines, which utilize messenger RNA (mRNA) technology, but little data has been collected on the condition following the Novavax vaccination, which doesn’t contain mRNA.

The U.S. Food and Drug Administration, when it authorized Novavax’s shot last summer, noted in fact sheets that clinical trials indicate there are increased risks of myocarditis and pericarditis after receipt of the Novavax vaccine. In the trial data submitted to the regulator, five cases of one or both conditions were reported in the vaccinated and zero were reported in placebo recipients. U.S. authorities have since cleared a Novavax booster and recently reached a deal to obtain up to 1.5 million additional doses on top of the original tranche.

The European Medicines Agency initially didn’t warn about inflammation after the administration of the Novavax vaccination but later added a warning to its product information.

Fifty cases of myocarditis, pericarditis, or myopericarditis after Novavax vaccination have been reported in Australia, according to the new study. Two have been reported in the United States and nine have been reported in Europe. Most have been among those aged 18 to 44.

While the exact mechanism for induction of myocarditis has yet to be confirmed, the study’s authors pointed out that the Pfizer, Moderna, and Novavax vaccines use nanoparticles to deliver a spike protein into the body.

“More research would be needed to understand the role of nanoparticles in the potential risk of vaccine-induced myocarditis,” they wrote.

The researchers, who also detected a higher-than-expected number of reports for the Pfizer and Moderna vaccines, said that health care professionals should be aware that Novavax may cause myocarditis, pericarditis, or both.

The study was funded by CIBERSAM, a research network, and was published in Drugs—Real World Outcomes on Feb. 14.

Novavax said in 2022, based on its interpretation of all of its clinical trials, that there was “insufficient evidence to establish a causal relationship” between the vaccine and the inflammation.

In an emailed statement in response to a request for comment on the new study, the company wrote: “Reports of myocarditis or pericarditis after Nuvaxovid vaccination are rare. While the risk of developing myocarditis or pericarditis is very low, both are important identified risks of COVID-19 vaccines, including Nuvaxovid.”

Nuvaxovid is the trade name for the company’s vaccine.

The company also claimed that the reports of inflammation “have generally been mild, self-limited, and clinically consistent with the literature describing myocarditis after mRNA COVID-19 vaccination.” A number of postvaccination cases among those who received the Pfizer or Moderna vaccine weren’t resolved months later, and some have ended in death.


Guidance

Some experts warn against getting one of the vaccines if a person has a history of myocarditis or pericarditis, or develops it after vaccination.

“Development of myocarditis or pericarditis after a dose of an mRNA COVID-19 vaccine (i.e., Moderna or Pfizer-BioNTech) or Novavax COVID-19 Vaccine is a precaution to a subsequent dose of any COVID-19 vaccine and subsequent doses should generally be avoided,” the U.S. Centers for Disease Control and Prevention states on its website.

Australian authorities claim that people who experienced myocarditis or pericarditis “can receive a COVID-19 vaccine” but advise consulting an expert “about the best timing of vaccination and whether any additional precautions are recommended.”

The regulator notes that some vaccine-induced myocarditis cases have led to death.

Some people who suffered from heart inflammation after a shot have gone on to get another one, according to case reports.

Two cases outlined in a paper by Australian doctors described a 26-year-old healthy male who experienced pericarditis after a second dose of Pfizer’s vaccine. The symptoms went away. Six months later, he received a booster produced by Novavax. He was diagnosed with pericarditis after experiencing similar symptoms, including chest pain.

A 25-year-old female, meanwhile, presented with chest pain and other issues 48 hours after receiving a second dose of Pfizer’s vaccine. The woman, diagnosed with myopericarditis, experienced “persistent symptoms” that required returning to the hospital multiple times over five months.

Symptoms eventually went away and abnormalities seemed to disappear. The woman then took a booster of Novavax’s vaccine. Five days later, she experienced chest pain and similar symptoms. She was diagnosed with myocarditis. The symptoms persisted two months post-vaccination, with no end in sight.

Well that’s a bummer; I did have hope about the non mRNA vaccine being “ok” to take.

Looks like it causes problems as well.

It’s not specifically the mRNA causing the heart problems, it’s the spike protein it replicates.
As does the adenovirus-vector J&J.

Novavax is a measured exposure of foreign antigen, but dammit it’s also the spike protein.

Seems we can’t win for losing….

(fair use applies)


Merck's COVID pill fails to prevent infection among household members
by Manas Mishra and Sriparna Roy
Tue, February 21, 2023, 6:51 AM EST

Merck & Co Inc said on Tuesday its COVID-19 pill was not effective at cutting the risk of coronavirus infections in people living with someone infected with the virus.

The results were similar to data from rival Pfizer Inc, whose COVID pill Paxlovid also failed to prevent infections among household contacts.

The two antiviral drugs are approved as treatments for individuals at risk of severe disease, but enthusiasm for the Merck pill has waned since it was shown to be only 30% effective versus 90% for Pfizer's Paxlovid.

Merck's late-stage trial enrolled over 1,500 participants, who were household contacts exposed to an individual with at least one symptom and had recently tested positive for COVID-19. Its Lagevrio pill, also known as molnupiravir, was given every 12 hours for five days and was compared with a placebo group.

Participants treated with the pill were 23.6% less likely to develop COVID than those given a placebo through day 14, failing to meet the main goal of the trial, Merck said.

Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorization in Dec. 2021 for patients with mild-to-moderate COVID that tested positive for the virus, and who were at risk of progressing to severe COVID.

Earlier in February, the U.S. Food and Drug Administration removed the need for a positive test for Merck and Pfizer's treatments in a bid to increase access to the drugs.

(fair use applies)

Pfizer Knowingly Allowed Dangerous Components In Its Vaccines
by Tyler Durden
Tuesday, Feb 21, 2023 - 05:00 AM

Authored by Yuhong Dong M.D., Ph.D and Qinyang Jiang via The Epoch Times,

Pfizer’s COVID-19 vaccine contains mRNA fragments called “truncated mRNA.” This is a serious issue on top of the vaccine’s life-threatening safety events. Stunningly, Pfizer submitted falsified mRNA analytical reports to multiple health authorities.

The issue of truncated mRNA led the European Medicines Agency (EMA) to raise a “major objection” before its December 2020 conditional approval of the vaccine. What has happened? How have these issues been considered resolved? This two-part series article will address the matter in depth and examine its potential consequences for human health.

Summary of Key Facts​

• Pfizer’s COVID-19 vaccine contains truncated mRNA, which the EMA flagged as a reason for its “major objection,” indicating a preclusion of their approval.
• Pfizer has not investigated the detrimental outcomes of truncated mRNA in its vaccines.
• Pfizer submitted Western blot figures to the Food and Drug Administration (FDA) and the EMA that were digitally generated—not from actual experiments.
• There has been an alarming lack of action taken by health authorities on this issue.
• Truncated mRNA potentially contributes to multiple vaccine-related injuries, including misfolded spike protein-induced fibrous blood clots, autoimmune disorders, and cancer.
• These problems with the Pfizer vaccine could have resulted in drastic product quality variations from batch to batch. This could explain the difference in adverse events experienced by vaccine recipients.
• The root cause of such irresponsible conduct by pharma and health authorities is a lack of ethics.

When you go to a supermarket and want to buy 10 bottles of whole milk for your children, you usually assume the chemicals and concentrations in these 10 bottles are the same or similar. No one would expect five of the bottles to be filled with watered-down milk while the other five were filled with yogurt.

Most store-bought foods meet our expectations because of regulations and quality control. The same criteria also exist in the pharma industry, including vaccine products.

We expect consistent physical and chemical parameters of key ingredients across different batches of drug or vaccine products. Consistency is the foundation that allows patients and consumers to have confidence in the safety and effectiveness of medications.

The CMC process—short for chemistry, manufacturing, and controls—involves defining manufacturing practices and product specifications that must be followed to ensure product safety and consistency between batches. This is a mandatory criterion for global health authorities to approve a drug or vaccine.

Controlling the quality of a traditional chemical product is relatively straightforward, but for a biological product, like an mRNA, things become more complicated.

What Is Truncated mRNA? Why Does it Matter?​

Our DNA contains gene codes composed of nucleotides. DNA makes proteins consisting of amino acids. Between the gene code and protein, there is a bridge molecule, a “translator”—called messenger RNA (mRNA).

The full-length mRNA sequence of the Pfizer vaccine coding for the spike protein is 4,284 nucleotides in length.

It consists of a 5′ CAP structure to prime its translation into a spike protein. It works like an ignition box of a car. At the end of the translatable region, the open reading frame, there is a stop codon, which is like a car’s brakes. If a truncated mRNA does not contain a stop codon, it fails to give a “brake” signal. The protein translation process will continue endlessly.


An mRNA translation into a protein and the role of the stop codon. (Courtesy: National Human Genome Research Institute)

Truncated mRNA’s missing stop codon is highly detrimental to humans. It can lead to the production of toxic protein products.

Pfizer’s COVID-19 Vaccine Contains Truncated mRNA​

The EMA is responsible for approving all medicinal products for human use in Europe, including drugs and vaccines. The Committee for Medicinal Products for Human Use (CHMP) is the EMA’s committee responsible for interpreting the agency’s opinions.

In an EMA assessment report coded EMA/CHMP/448917/2021, the EMA requested that Pfizer address the impurities of its vaccine product, which the EMA report described as “truncated and modified mRNA.”

Pfizer’s report to the EMA clearly showed that Pfizer’s vaccine contained impurities, as indicated by “Peak 1” in the graph below, based on a screenshot from page 14 of the EMA’s August 2021 report.

Read more here...

View: https://www.youtube.com/watch?v=fWVxVd6IGgg

mRNA in blood after 28 days
Dr. John Campbell
Feb 20, 2023
19 min 42 sec

SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination https://onlinelibrary.wiley.com/doi/1... Journal of Pathology, Microbiology and Immunology - the APMIS journal Copenhagen University Hospital CONFLICT OF INTEREST Authors have no conflicts of interest to declare. Denmark used Pfizer-BioNTech (BTN162b2) Moderna (mRNA-1273) Both code for production of the full-length SARS-CoV-2 spike protein mRNA is encapsulated in lipid nanoparticles Non replicating The modified nucleotide sequences allow perfect identification of the vaccine sequences Patients with chronic hepatitis C virus (HCV) infection Received mRNA vaccinations To monitor HCV infection, RNA was extracted from patient plasma In 10 of 108 HCV patient samples, full-length or traces of SARS-CoV-2 spike mRNA vaccine sequences were found in blood, up to 28 days after COVID-19 vaccination. Professor Hoiby https://studio.youtube.com/video/hkop... INTRODUCTION Upon intramuscular injection, the vaccine mRNA is taken up by muscle and immune cells, and transported to the regional lymph nodes, and concentrated in the spleen The vaccines consist of nonreplicating mRNA, expected to naturally decompose, both within the cytosol after translation and at the injection site. Half-life of mRNA translation, estimated from hours to a day. Translation is described to span up to 10 days The Infectious Diseases Society of America (IDSA) https://www.idsociety.org/covid-19-re... Vaccine mRNA is degraded quickly, by normal intracellular processes, there is no evidence for long-term detection of mRNA vaccines Method used in Denmark Genotyping whole RNA genome sequencing NCH and SARS-CoV-2 mRNA, directly from plasma samples We describe the unexpected finding of SARS-CoV-2 vaccine mRNA sequences Five consecutive sequencing runs (May 2021 to the end of June 2021) Five negative controls and five HCV-positive controls RESULTS Both mRNA vaccine sequences have been modified and are only ~70% identical to the spike reference genome on a nucleotide level, making them distinct from circulating infectious SARS-CoV-2 sequences. Of the 108 patient samples, 10 samples (9.3%) had partial or up to full sequences of the vaccine mRNA sequence DISCUSSION Analysis of mRNA vaccine function has focused on the immune response, and on protection of vaccinated individuals The LNPs have been reported to be rapidly cleared by immune cells, and mRNA rapidly degraded We expect that vaccine mRNA detected in plasma is contained within LNPs To our knowledge, our study is the first to detect Pfizer-BioNTech and Moderna COVID-19 mRNA vaccine sequences in blood after vaccination, and therefore provides new knowledge regarding the timeframe in which the mRNA can be detected. A future prospective study to establish the half-life of mRNA vaccines in vaccine recipients could be performed (using mRNA vaccine-specific PCRs)

View: https://www.youtube.com/watch?v=H5MqkbFt2sU

Vitamin D Cut Covid Deaths in HALF - Covid News
Peak Prosperity
Feb 7 2023
22 min 22 sec

PART 2: https://peak.fan/76a
Vitamin D deficiency has been linked to higher risk of viral respiratory infections.P Patients who take a daily dose of vitamin D are less likely to experience complications and die from coronavirus, according to a new study in the US. The vitamin was linked to higher levels of immune cells in the blood and much lower inflammatory markets, scientists at Boston University’s school of medicine found. This meant there were far fewer cytokine storms, a potentially deadly overreaction of the immune system sparked by coronavirus that overloads the blood with proteins.

(fair use applies)


Outsmarting COVID-19: Weaponizing the Spike Protein Against Itself To Prevent Infection
By Biophysical Society
February 21, 2023

By creating a drug that’s based on part of the SARS-CoV-2 spike protein, researchers can block the virus from entering cells.

The virus that causes COVID-19, called SARS-CoV-2, uses its spike protein in order to stick to and infect our cells. The final step for the virus to enter our cells is for part of its spike protein to act like a twist tie, forcing the host cell’s outer membrane to fuse with the virus. Kailu Yang, in the lab of Axel Brunger, colleagues at Stanford University, and collaborators at the University of California Berkeley, Harvard Medical School, and the University of Finland have generated a molecule based on the twisted part of the spike protein (called HR2), which sticks itself onto the virus and prevents the spike protein from twisting. Their research shows that it prevents cells from infection even with new SARS-COV-2 variants. Yang’s work was published in the Proceedings of the National Academy of Sciences in October and was presented on Tuesday, February 21 at the 67th Annual Biophysical Society Meeting in San Diego, California.

Other treatments for COVID-19 have worked by sticking to the outside of the spike protein to block it from infecting cells, but they’ve had drawbacks. For example, bebtelovimab was an antibody treatment that targeted the spike protein, however, it didn’t work well against new COVID-19 variants because that part of the spike protein has mutated over time. Yang and Brunger are hopeful that their molecule, which they call the longHR2_42 inhibitor, is the lead compound to develop a new type of antiviral therapeutic to prevent infections even with new variants.

The reason the longHR2_42 inhibitor may work against an evolving virus is that it is based on part of the spike protein that hasn’t changed even as other parts have. “In the virus, there are two parts of the spike protein that come together forming this bundle. So we simply took a short piece of one part of this bundle, and by synthesizing that small piece chemically, it can insert itself into the spike protein and prevent the virus from infecting cells,” Brunger explained. Past research from before this COVID-19 pandemic aimed to create a similar molecule that would work to block infection of the SARS coronavirus, but those past attempts weren’t as effective as the longHR2_42 inhibitor.

Brunger believes their molecule is more effective than past attempts due to Yang’s work determining a detailed structure of the twisted together parts of the SARS-CoV-2 virus, called the postfusion so-called HR1HR2 complex, so they knew longer molecules would help block the spike protein from twisting into the HR1HR2 complex in the first place. “We made the molecule a little longer than previously published work based on the structure, and indeed, we confirmed in our fusion and infection assays that this longer piece inhibits much better,” Brunger said.

The team is currently testing the longHR2_42 inhibitor in mice infected with SARS-CoV-2 (collaboration with Giuseppe Ballisteri and co-workers, University of Finland). They are hopeful that they will be able to deliver it to people via an inhaler so that it gets to the airway, which is exactly where you want to treat an early infection to prevent infection from becoming severe. “The moment people start developing sniffles will be the time to take it,” Brunger explained.

Reference: “Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein” by Kailu Yang, Chuchu Wang, Alex J. B. Kreutzberger, Ravi Ojha, Suvi Kuivanen, Sergio Couoh-Cardel, Serena Muratcioglu, Timothy J. Eisen, K. Ian White, Richard G. Held, Subu Subramanian, Kendra Marcus, Richard A. Pfuetzner, Luis Esquivies, Catherine A. Doyle, John Kuriyan, Olli Vapalahti, Giuseppe Balistreri, Tom Kirchhausen and Axel T. Brunger, 19 September 2022, Proceedings of the National Academy of Sciences.
DOI: 10.1073/pnas.2210990119

(fair use applies)


HHS releases records to GOP-led panel probing COVID "Wuhan lab leak" theory
Scott MacFarlane
Wed, February 22, 2023, 9:56 AM EST

The Health and Human Services (HHS) Department has released 900 pages of records to the House Select Subcommittee on the Coronavirus Pandemic, according to an HHS official, as the Republican-led panel launches its review of the Biden administration's handling of the pandemic crisis.

Committee chairman Rep. Brad Wenstrup, Republican of Ohio, had requested records from the agency, including from National Institutes of Health Director Dr. Francis Collins, former White House COVID adviser Dr. Anthony Fauci and Health and Human Services Secretary Xavier Beccera. The panel, which was previously controlled by Democrats, said it is probing whether COVID-19 originated from a lab in Wuhan, China and the Chinese Communist Party covered it up, as well as whether U.S. taxpayer dollars were being sent to the lab.

The committee requested phone records, calendars and dozens of sets of internal records from top federal health officials. Though HHS did not specify what records it shared with the panel Tuesday evening, an agency spokesperson told CBS News, "The U.S. Department of Health and Human Services is committed to working in good faith to address the Select Subcommittee's oversight requests."

Wenstrup told CBS News he will consider subpoenas against Fauci, Becerra and other key officials, if full responses and answers are not provided to the panel's questions about COVID-19's origins and the federal agencies' response to the outbreak.

"I think there will be subpoenas for some," Wenstrup said. "Just being honest with you — I would hope that we don't have to do it very often."

The theory of a Wuhan "lab leak" has been previously argued by Senate Republicans and has been a particular focus of GOP congressional investigators and some cable news talk segments.

Though Fauci has answered a series of questions about the theory, including in Senate hearings, Wenstrup said Fauci has not done so to the same extent before a House panel.

"We have concerns about (Wuhan), and the type of research and studies that were taking place there," Wenstrup said. "So, we do want to dig in to that."

The panel's top ranking Democrat, Raul Ruiz, of California, said the committee must avoid allowing the investigation to fuel conspiracy theories about COVID. Ruiz told CBS News, "I want to make sure that we avoid — or they avoid — the extreme partisan rhetoric or a witch hunt that will villainize their targets."

Ruiz said, "I don't disagree that there is value in identifying the mechanism of identifying a virus quickly and our ability to quickly contain them. The question here is the method of the investigation." He added, "We're not interested in extreme partisan rhetoric that only fuels conspiratorial accusations, (which) villainizes individuals from the administration. We're interested in taking a scientific approach in order to save American lives."

The subcommittee on the pandemic is beginning its work under Republican control as the U.S. reaches the three-year mark of the pandemic. Wenstrup told CBS News the panel's initial set of investigations will also probe the impact of school closures and stay-at-home orders.

"I would hope that we do it so that we can bring some clarity and transparency to the American people," Wenstrup said. "The American people have a lot of distrust right now because they felt like they were told different things at different times."

Ruiz argues the panel should also explore the impact of the pandemic on the mental health of Americans. The subcommittee, he said, should "ensure the pandemic response is done with equity, making sure that those most vulnerable receive the attention and resources to help save as many lives as we possibly can, to really understand the experience of isolation."

Some Democrats have sharply criticized the inclusion on the panel of Rep. Marjorie Taylor Greene, Republican of Georgia, who has been accused of espousing conspiracy theories. Wenstrup said, "She has told me that she's concerned about her children and the effects on businesses, which is part of what we want to take a look at." He said, "I think those are reasonable things for us to look into."

Greene did not immediately return requests for comment.

Wenstrup and Ruiz both pledged efforts for bipartisan work in interviews with CBS News, but both acknowledged the pandemic responses by state and federal governments have aroused fiercely partisan reactions. Wenstrup said he hopes that he and Ruiz "can change that narrative a little bit and we can move forward in a professional way and have America see the way that we're trying to conduct this and get the answers for America so that we're a better country and more prepared in the future."

Ruiz said, "When you have individuals who are claiming false conspiracy for partisan reasons, you're creating doubt in the scientific process of vaccines that we know has saved countless of lives already in the millions."

"I don't care if you're a Republican or Democrat or independent," Ruiz said. "I care about saving lives as a physician."

(fair use applies)


Florida Surgeon General Joe Ladapo investigated for allegedly falsifying Covid report
Arek Sarkissian
Wed, February 22, 2023, 8:59 PM EST

TALLAHASSEE, Fla. — The Florida Department of Health’s inspector general last fall investigated Joseph Ladapo, the state’s surgeon general, after the agency received an anonymous complaint alleging he falsified a report focusing on the safety of Covid-19 vaccines for young men.

Among other things, the complainant alleged Ladapo committed “scientific fraud” and “manipulated data” in a report that Ladapo later used to claim that the Pfizer-BioNTech and Moderna Covid-19 vaccines could increase the risk of cardiac death among young men, according to the complaint. Both brands use mRNA technology, which Ladapo contends was rushed to the market by the urgency of the pandemic without the proper testing.

“The analysis performed in DOH did not find this,” the individual wrote without providing evidence, according to the complaint. “He manipulated the final draft of the analysis.”

Ladapo’s report was used as evidence in vaccine guidance he released in October that came under heavy criticism from the medical community, which said the surgeon general’s stance that the vaccine posed a health risk in healthy young men was flawed and went against Covid-vaccine recommendations from the Centers for Disease Control and the American Academy of Pediatrics. The guidance even prompted Twitter to temporarily block a social media post from the surgeon general promoting the analysis, though the company later restored it.

The inspector general’s office opened the investigation in November after it received the complaint and later closed it an undisclosed date after the complainant didn’t respond to follow-up questions regarding the accusations, according to state documents that include a copy of the original complaint.

Nothing is known about the complainant, and anyone can submit a grievance with the Department of Health’s inspector general. But the individual appeared to have detailed knowledge of state health agencies, according to the documents the Florida Department of Health provided to POLITICO.

Ladapo on Wednesday called the accusations against him untrue and said the report in question was completed by a team of staffers at the Florida Department of Health.

“It’s factually false,” Ladapo said in an interview with POLITICO. “I trust the team — they used our Florida data, they performed the analysis, and we’re an accredited public health organization.”

Florida Gov. Ron DeSantis hand-picked Ladapo, a Harvard-educated medical doctor, to be his top health official in 2021. Ladapo has long questioned the safety of Covid-19 vaccines and at one point joined a petition to urge the FDA against quickly authorizing the Pfizer and Moderna vaccines. Ladapo found a national audience early in the pandemic by writing opinion pieces in The Wall Street Journal and USA Today that criticized community lockdowns and the use of facemasks.

The November complaint against Ladapo asked the inspector general to speak with employees at the state Department of Health Communicable Disease Division, who helped write earlier drafts of the report that was eventually released. Emails were kept to a minimum, the complainant wrote, and notes were hand-delivered.

“You may not find these documents by email, as they get transmitted by hand,” the complainant stated, according to state documents. “But they have been seen by several individuals.

“Lots of people know about this,” the individual stated.

Ladapo, however, stood by his Covid guidance and defended his stance on vaccines.

“Between my scientific experience, and training and the fact that I am only comfortable saying the truth and speaking the truth, I felt completely fine with that announcement,” Ladapo said. “That’s what the data show.”

Ladapo said experts who have rejected his ideas are unwilling to face what he called honesty in modern medical care.

“It really strains credulity to try and write this off as being anything but related to the safety of these mRNA Covid vaccines,” Ladapo said. “I think people should know that it’s OK to believe what their eyes are showing them.”

(fair use applies)


New research reveals possible COVID vaccine blood clot connection
by Flinders University
February 22, 2023



Graphical abstract. Credit: Cell Reports Medicine (2023). DOI: 10.1016/j.xcrm.2023.100971

A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.

The COVID-19 Vaccine Immune Responses Study (COVIRS), published in Cell Reports Medicine, tracked the immune responses of 102 adults of varying ages, all living in South Australia where there was no community transmission of SARS-CoV-2 at the time.

Participants had their bloods taken immediately after each dose of either the Oxford/AstraZeneca or Pfizer/BioNTech COVID-19 vaccines to assess early immune response.

They were also tested 28 days after every immunization to evaluate B and T cell activity. Both are critical, as B cells produce antibodies and T cells kill infected cells.

The vaccines are alike in the sense that they induce the immune system to recognize and protect against the SARS-CoV-2 virus, but they differ in how this is achieved.

The Pfizer vaccine uses mRNA technology to induce host cells to produce the SARS-CoV-2 Spike protein, while the AstraZeneca vaccine uses a harmless virus (a chimpanzee adenovirus) to encode the Spike protein.

Head of SAHMRI's Systems Immunology Laboratory and Flinders University Professor David Lynn led the study, using a method of biological analysis known as 'multiomics' to examine immune responses in many different ways in thousands of blood samples.

Professor Lynn says this comprehensive analysis of immune responses to these different vaccines has revealed lots of new information that'll help inform future vaccine design.

"After the first dose, we were surprised to find the Oxford/AstraZeneca vaccine elicits an unexpected memorylike response in the immune system, recognizing the vaccine as if it's something it's seen before," says Professor Lynn, from the College of Medicine and Public Health at Flinders University.

"This response is targeted against the adenovirus vector in the vaccine, not the Spike protein and the intensity of this response correlates with the expression of proteins that act as a pre-cursor to thrombosis, or blood clotting.

"While Vaccine-induced immune thrombotic thrombocytopenia (VITT) is an extremely rare side effect associated with the Oxford/AstraZeneca vaccine that none of the participants developed during the study, this research offers a potential explanation for the connection between the Oxford/AstraZeneca vaccine and the cases of VITT that've been reported."

The study also found those who'd only had two doses of the Oxford/AstraZeneca vaccine generally produced lower amounts of antibodies and less of a specialized type of T-cell that helps with antibody production; compared to those who had two doses of the Pfizer/BioNTech vaccine.

However, this was rectified once they had their third booster dose of an mRNA vaccine, illustrating the importance of booster doses.

The study added evidence to the notion that COVID-19 vaccines offer some people more effective protection than others.

The reasons for this variability are not well understood, but Professor Lynn says age is a factor, with older people generally having a lower immune response after two doses. Fortunately, a third booster dose was highly effective at overcoming this.

Immune responses induced immediately after vaccination predicted the subsequent B and T cell response to the vaccine measured a month later.

"One to two days after initial vaccination we measured gene expression responses in the blood which correlated with adaptive immune responses that mediate protection 28 days later," Professor Lynn says.

A further surprise to researchers was the finding that feeling unwell after a vaccine dose may in fact be linked to its effectiveness.

"People who showed symptoms of fatigue and fever immediately after the third dose were more likely to have better T-cell responses. T-cells play a vital role in vaccine efficacy as they can directly kill viral cells," Professor Lynn said.

The study was a major collaboration involving SAHMRI, Flinders University, Murdoch Children's Research Institute, The University of Melbourne, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, University of New South Wales, The Kirby Institute, Alfred Hospital, Monash University, AstraZeneca and the Royal Adelaide Hospital.

Overall, this project has provided important new insights into the early immune responses to these vaccines and offers a greater understanding of how they work to protect against COVID-19.

(fair use applies)


What the end of COVID trackers means for the future of the pandemic
YOURI BENADJAOUD and EMMA EGAN - GMA
Thu, February 23, 2023, 5:03 AM EST

As the pandemic seemingly enters a new phase with the public health emergency ending in early May, many COVID data trackers are shutting down, no longer sharing data such as number of cases or hospitalizations, despite about 500 Americans dying each day from the disease.

Experts interviewed by ABC News detail how the onset of the pandemic brought a slew of data trackers to monitor numbers to inform officials. They warn that investments in epidemiological tracking can’t dwindle, especially as respiratory illnesses like influenza and RSV placed a heavy burden on some hospitals across the nation this past winter.

John Hopkins University reported their Coronavirus Resource Center will be shut down in early March. The site was one of the first to track real-time COVID data and was widely appreciated – even the White House relied on the site in the very beginning of the pandemic to learn about the outbreak that was occurring abroad, explained Dr. Blythe Adamson Ph. D., CEO and founder of infectious economics and former member of the White House Coronavirus Task Force, told ABC News.

“Clearly the challenges, especially at the earliest outset of a pandemic, was that there was not really good data infrastructure to report aggregate data, like case counts. The Johns Hopkins tracker played a real vital role in filling in some of those gaps,” said John Brownstein, Ph.D., an ABC News contributor and chief innovation officer at Boston Children's Hospital.

Other trackers, like the one managed by the Department of Health and Human Services are being shut down as well, in favor of the dashboard managed by the Centers for Disease Control and Prevention.

Accurate data has been essential for public health officials and policymakers to develop and adjust COVID policies. Yet, almost no jurisdiction is widely imposing any policies like mask-wearing or social distancing.

“These trackers are only as valuable as the actions that they inform and where we're at in the pandemic. There are still a lot of important decisions that need to be made, actions that can be taken and I would argue that the type of information that we need to make those decisions is different now than it was at the beginning of the pandemic,” Adamson said.

Losing momentum on the investments made in public health data may place communities in vulnerable positions, experts say.

“The investments that took place in COVID should extend out to other public health crises and I think that has always been a worry, that post-response we'd be left with a graveyard of software code that would basically be never utilized and that would be such a shame,” Brownstein said.

At-home tests have now made case numbers less reliable, although officials continue to encourage anonymously reporting tests to MakeMyTestCount.org – a site led by the NIH. Experts say tracking cases can still help inform public health agencies.

“For infectious diseases, it's very important for public health agencies – I'm really referring to state and local health departments and CDC – to continuously monitor how many people are getting sick, who is getting sick and of course to evaluate the pathogen itself,” said Dr. Jay Varma, director of the Cornell Center for Pandemic Prevention and Response.
Tracking cases is also important because it alerts officials of potential surges. There have been some notable ones like the Delta surge in the summer of 2021 which impacted many hospitals.


PHOTO: Weekly Trends in Number of COVID-19 Cases in The United States Reported to CDC (ABC News Photo Illustration, CDC)

12/14/20: First COVID dose administered

04/30/21: 100 million fully vaccinated

08/31/22: First bivalent dose administered

01/20/23: 50 million received bivalent shot

Yet, the Omicron surge obliterated its predecessors in terms of the sheer numbers of cases. Since then, small rises in cases have all been attributed to offshoots of the variant.

“I don't think we fully know the intrinsic versus extrinsic factors that are influencing these cycles. There's absolutely a behavioral component. There's an intrinsic biological component. We're seeing waves of different magnitude, at three to six months increments,” Brownstein said.

“The reality is sometimes it can take many years after a new pathogen enters the world for us to understand what these patterns are, and what the factors are that drive them,” Varma said.

COVID numbers will continue to ebb and flow, yet a serious surge would most likely require a completely new variant, experts believe.

“I think, without a doubt, we will have surges. The frequency and size of those surges is still very hard to predict. In all likelihood, we will see a bigger surge at some point in the coming year or two. We will likely be challenged with a new variant, no mitigation strategies and waning immunity and I think that recipe will lead to a surge,” Brownstein said.

In general, predicting COVID numbers – just like predicting how the stock market will do – is an almost impossible task.
“One of the most important lessons of the COVID pandemic has been that subject matter experts, like myself, have to be very humble about making predictions for the future,” Varma said.

However, experts are optimistic that things will get better. “The most likely scenario is that through repeated infections, and through vaccination, COVID will overtime cause fewer hospitalizations and deaths than it has over the past few years,” he added.

(fair use applies)


China's COVID-19 epidemic has 'basically' ended, but not completely over
by Beijing newsroom; Writing by Bernard Orr
Thu, February 23, 2023, 2:35 AM EST

BEIJING (Reuters) -Health authorities in China said on Thursday the country's COVID-19 epidemic has "basically" ended, but it is not completely over as it found seven imported cases of the highly-transmissible XBB.1.5 variant since Jan. 8.

Officials, speaking at a news event with several departments attending, said China's "major decisive victory" over COVID has set an example for populous nations in prevention and control.

Last week, China's top leaders declared a "decisive victory" over COVID, claiming the world's lowest fatality rate, although experts questioned data as the virus surged across the country recently after largely being kept at bay for three years.

The country strengthened its healthcare system in anticipation of the virus spreading to rural areas. Officials said at the press briefing on Thursday critical care beds had expanded to 404,000 from 198,000.

Health officials and experts were also monitoring the XBB.1.5 sub-variant of Omicron for months. On Jan. 4, data had showed no new variant was found in the country.

Officials said on Thursday one local case of the variant was linked with an imported case on Feb. 3.

Zoner said:

https://twitter.com/i/web/status/1629108996492632066

View: https://twitter.com/zombywoof2022/status/1629108996492632066?s=46&t=a5aTYUO4i5Fx_SDjUUtpqQ

Click to expand...

View: https://twitter.com/tradsperger/status/1629144893426728961?s=46&t=a5aTYUO4i5Fx_SDjUUtpqQ

Zoner said:

https://twitter.com/i/web/status/1629108996492632066

View: https://twitter.com/zombywoof2022/status/1629108996492632066?s=46&t=a5aTYUO4i5Fx_SDjUUtpqQ

Click to expand...

That chart was comparing Austria to Belgium. Here's an article about what's going on in Austria:

(fair use applies

COVID-19 News: What’s happening In Austria? COVID-19 Infections And Hospitalizations Are Up And A Number of New Sub-Lineages Emerging
Thailand Medical News
February 23, 2023

Authorities and governments around the world are not only relaxing all COVID-19 measures and safety protocols but are also going with the constant narrative that theCOVID-19 disease is now endemic and that we have to learn to live with the SARS-CoV-2 virus.

Does living with the virus means roughly about 340 to 400 Americans dying a week (Actual figures could be much higher!) and an average of about 35,000 Americans contracting the virus each day?


Does living with the virus means that we have to endure the various debilitating conditions associated with Long COVID?

Countries like Taiwan saw 14,000 new COVID-19 infections and 37 COVID-19 deaths in the last 24 hours while South Korea saw 10,845 new cases and 22 deaths for the same period.


COVID-19

In fact, if one was to look at theCOVID-19 figures in various countries that are truthfully disclosing data though they might not be accurate due to lack of testing and also due to strategies to downplay the crisis, it is very clearly seen that COVID-19 is still wreaking havoc everywhere!

Unfortunately, COVID-19 is now the leading ‘silent killer’ in the world but no mainstream media or medical news sites are allowed to report that as those controlling the narratives do not want people to know this plus it might reflect badly on some of the prophylactic shots that they are still promoting!

However, strangely no COVID-19 News coverages are talking about what is ‘brewing’ in Austria!

View: https://twitter.com/ianmSC/status/1626688424425185280

COVID-19 infections and deaths have been climbing steadily in the country over the last 6 weeks.


Austria: Coronavirus Pandemic Country Profile

Hospitalization rates in Austria have also been going up.


Epidemiologische Parameter des COVID19 Ausbruchs, Österreich

View: https://twitter.com/Jean__Fisch/status/1627242470558863360

For a country with a population of about 8.9 million people, COVID-19 News coverages reporting an average of between 6,000 to 7,000 daily COVID-19 infections is a worrying sign. (Again, actual figures could be much higher!)

Interestingly, a number of new sub-lineages have either emerged in Austria or have been found in circulation in the country.

In January 2023, a new sub-lineage of CH.1.1.4 with spike mutation was spotted in the country.


XAY.3, a unique recombinant variant involving the Delta sub-lineage emerged solely in Austria bearing the mutations ORF1a:T2611I, ORF1a:T4355I, and ORF1b2087V.


An XBB.1 sub-lineage with spike mutation F486A was found in circulating also in Austria about 2 weeks ago.


A CH.1.1.1 sub-lineage with spike mutation S486P was also detected in Autria a week ago.


Recently a recombinant BA.2.75.BA.5 variant was also detected in Austria and also in other countries.


And most recently, the XBB.1.5 sub-lineage with a spike P251S mutation was also found in the country.


Interestingly, SARS-CoV-2 variants or sub-lineages with the spike mutation F490S seems to be driving up COVID-19 cases in Austria.

View: https://twitter.com/T_Brautigan/status/1628331486779777024/photo/1

Various independent researchers are cautioning about what could be possibility brewing in Austria and are calling for more testing, more sequencing and safety measures to be put into place fast. Many are claiming that new SARS-CoV-2 sub-lineages that could display immunity imprinting and ADE and also contribute to more disease severity could be emerging or circulating in the country but more detailed urgent research is warranted before this can be confirmed.

(fair use applies)


FDA authorizes combination flu-COVID test for home use
today

WASHINGTON (AP) — The Food and Drug Administration on Friday approved the first combination test for flu and C OVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease.

The Lucira COVID-19 & Flu Home test, which can be purchased without a prescription, uses self-collected nasal swab samples and delivers results in about 30 minutes, the agency said.

While at-home COVID tests are readily available, this is the first home test for influenza A and B, commonly known as the flu. The test was granted an emergency use authorization, which facilitates the availability of “medical countermeasures” during public health emergencies.

Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the authorization “a major milestone in bringing greater consumer access to diagnostic tests that can be performed entirely at home.”

The agency said the test is for individuals “with signs and symptoms consistent with a respiratory tract infection” and said it can be used on children as young as 2, with adults collecting the samples.

It recommends that tests be reported to healthcare providers and cautions that there is a risk of false positive and negative results. “Individuals who test negative and continue to experience symptoms of fever, cough and-or shortness of breath may still have a respiratory infection and should seek follow-up care with their healthcare provider,” the agency said.

Citing the impact of COVID and RSV, another respiratory infection, the FDA said it “recognizes the benefits that home testing can provide” and would work to increase the number of tests available.

(fair use applies)


Not enough data to support multiple annual COVID boosters, U.S. CDC advisers say
Aditya Samal
Fri, February 24, 2023, 3:26 PM EST·2 min read

(Reuters) - There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with weakened immune systems, an expert advisory group to the U.S. Centers for Disease Control and Prevention (CDC) said on Friday.

The COVID-19 working group of the CDC's Advisory Committee For Immunization Practices (ACIP) supported an annual booster campaign, likely in the fall, especially for populations considered at high risk, Dr. Sara Oliver, a CDC official who heads the group, said during a meeting of the agency's outside advisers.

The agency currently recommends older and immunocompromised people receive COVID booster shots more frequently since vaccine effectiveness usually wanes faster for those populations compared to younger people with robust immune systems.

In the spring of 2022, the CDC recommended immunocompromised and people over age 50 receive an additional shot if they had received their first booster at least four months earlier.

The CDC advisers did not vote on new recommendations for how the COVID-19 shots should be administered on Friday.

But ACIP advised showing flexibility in recommendations for those with compromised or weakened immune systems to allow more frequent doses for those most vulnerable to severe COVID.

Both the CDC and the U.S. Food and Drug Administration are working on how to best update COVID vaccines to target circulating variants annually, similar to flu vaccine campaigns.

About 53.3 million people in the United States - around 16% of the U.S. population - have received a COVID-19 booster shot since updated versions of the vaccines were authorized in September.

That compares with 230 million people, around 70% of the population, that received an initial two-dose series of the COVID vaccines.

(fair use applies)


Nasal Covid vaccine shows promise in early clinical trial
Denise Chow - NBC News
Fri, February 24, 2023, 3:26 PM EST

An experimental nasal vaccine provided strong protection against Covid infection, according to preliminary results from a Phase 1 clinical trial.

The vaccine, developed by a startup called Blue Lake Biotechnology Inc., was found to reduce the risk of symptomatic Covid infections by 86% for three months in people who received it as a booster dose. Existing booster shots in the United States reduce symptomatic infections by 43% in people 18 to 49 over one to two months, according to a study published in November by the Centers for Disease Control and Prevention.

The results from the clinical trial offer an early but tantalizing glimpse at how a next-generation Covid vaccine could be more effective at stopping the coronavirus in its tracks.

Scientists have said nasal vaccines could provide better protection against Covid compared to those that are injected into the arm.

Because these vaccines are sprayed in the nose, they are thought to more readily jump-start the immune system against respiratory viruses. Essentially, nasal vaccines bolster immune protection right where the virus enters the body, setting up a more targeted line of defense.

The idea is to give the immune system a heads-up so that the virus “won’t even have a chance to take hold,” said Dr. Benjamin Goldman-Israelow, an assistant professor of medicine at the Yale School of Medicine, who is not involved with Blue Lake’s clinical trials.

Goldman-Israelow’s own research in animals has shown similarly promising levels of protection. In a study published in October in the journal Science, he and his colleagues demonstrated that a nasal vaccine booster induced a strong immune response in the upper airway and was more effective at blocking Covid infections than vaccines injected intramuscularly.

Despite their promise, progress on nasal vaccines in the U.S. has lagged behind other countries. While several versions of a nasal vaccine are in development, most are in preclinical stages. Aside from Blue Lake's vaccine, only one other vaccine, from researchers at Mount Sinai in New York City, has reached human trials.

Nasal Covid vaccines have been approved in India, Iran and Russia, and two others are in use in China, along with an inhalable version that was approved in September for use as a booster. But, few details of their efficacy have been publicly released so far.
Phase 1 results

Blue Lake’s Phase 1 trial included 72 participants ages 18 to 55 who had already received at least two doses of mRNA vaccines, as well as unvaccinated healthy adults. The trial began in August 2021 and the scientists will continue collecting data from participants into December.

The findings, which were released earlier this month, are still preliminary, and more research involving more people is needed before broad conclusions can be drawn. But the vaccine appears to be showing promise so far.

“When we crunched the numbers, we had longer duration and better protection than mRNA vaccines — that’s very exciting,” said Biao He, founder and CEO of the Athens, Georgia-based startup and a professor of infectious diseases at the University of Georgia College of Veterinary Medicine.

“This is only Phase 1 and we need to do at least three phases, but we’re very encouraged and excited about this,” He said.

The vaccine uses a type of parainfluenza virus encoded with the coronavirus’s spike protein to train the immune system to recognize and fight it. The same parainfluenza virus, modified so that it doesn’t make people sick, is also used in vaccines administered to dogs to protect against kennel cough.

Once inhaled, bits of the virus replicate inside the nasal cavity for several days at levels that are just enough to trigger an immune response without actually getting a person sick.

This works by leveraging the finely tuned way that the respiratory system encounters and identifies foreign invaders, Goldman-Israelow said.

Unlike more “sterile” environments in the bloodstream, the nose and lungs have to look for specific danger signals to separate real threats from more innocuous substances.

“Your lungs are always encountering what you breathe in, and if they responded really violently and had intense immune responses against everything they encountered, you wouldn’t be able to breathe,” Goldman-Israelow said.

If nasal vaccines are given as boosters, the body will already be primed to recognize the coronavirus, and can thus mount a faster immune response at the site where the virus enters the body, he added.

In their Phase 1 trial, the researchers also recorded fewer side effects with their vaccine compared with shots. Some people reported flu-like symptoms such as sore arms, muscle aches and fever after receiving Covid injections, but He said Phase 1 participants experienced mild side effects like a runny nose, or none at all.

“The side effects from other vaccines may have discouraged some people from getting it, but in the testing we’ve done so far, our vaccine was very well tolerated,” he said.

The researchers are hoping to begin the next phase of clinical trials soon, He said, and are aiming to expand the study to include around 400 participants in the U.S. and Europe.

He said he hopes more positive results will spur additional funding to develop and test nasal vaccines — not just for Covid, but also other diseases.

If the current pace of vaccine development is any indication, there's reason for optimism, Goldman-Israelow said.

“Despite a huge anti-vaccine front, there’s also a lot of people who really want vaccines and want protection,” he said. “There seems to be people interested in this type of stuff and would like vaccines to work even better, and I believe there’s potential for them to work better.”

CORRECTION (Feb. 24, 2023, 5:06 p.m. ET): A previous version of this article misstated the results of the CDC study on mRNA boosters. It was 43% effective in people ages 18 to 49 over one to two months, not in people ages 65 and younger over three months.

(fair use applies)


Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine
by Sriparna Roy
Fri, February 24, 2023, 9:22 AM EST

(Reuters) -Pfizer Inc and its German partner BioNTech SE said on Friday they filed an application to the U.S Food and Drug Administration (FDA) for a full approval of their Omicron-adapted COVID-19 vaccine.

The companies are seeking approval of the updated vaccine both as a primary course and a booster dose for individuals 12 years of age and above.

Advisers to the FDA in January had unanimously voted in favor of using the same coronavirus strain for the initial COVID-19 vaccine doses and the boosters to simplify the vaccination regimen in the United States.

If the application is approved, individuals will be able to receive the Omicron-adapted vaccine for their primary dose, rather than using the original vaccine for the primary course before having access to the bivalent vaccine, the company said.

The updated vaccine is currently available in the United States under emergency-use authorization as a single booster dose for people aged 5 years and above, and as the third dose in the three-dose primary series for children 6 months through 4 years of age.

U.S. Centers for Disease Control officials in January had said the updated COVID-19 boosters helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines perform against these fast-spreading strains.

In Europe, the Omicron-tailored vaccine is already authorized by the European Commission for individuals aged 12 years and above.

The companies plan to submit applications to the European Medicines Agency to also include the updated vaccine as a primary course of vaccination in individuals aged 5 and older and as a primary course of vaccination and booster dose for children aged 6 months through 4 years.

Ray Armat, Ph.D.
@RayArmat
3h

New paper, 2 years late!
Study of 5 million vaccine recipients by Georgia Dept. of Public Health:
"Those with concurrent COVID infection within 21 days post vaccine had an 800% increased risk of ischemic stroke & 523% increased risk of hemorrhagic stroke"
View: https://twitter.com/RayArmat/status/1629665329109401601?s=20

jward said:

Ray Armat, Ph.D.
@RayArmat
3h

New paper, 2 years late!
Study of 5 million vaccine recipients by Georgia Dept. of Public Health:
"Those with concurrent COVID infection within 21 days post vaccine had an 800% increased risk of ischemic stroke & 523% increased risk of hemorrhagic stroke"

https://twitter.com/i/web/status/1629665329109401601

View: https://twitter.com/RayArmat/status/1629665329109401601?s=20

Click to expand...

This explains a lot. Maybe the sudden adult death syndrome has to do with catching covid after the vaccine - the combination. I wonder if an asymptomatic or mild case also causes this, which is why the victim's families didn't put two and two together. ???

HD

View: https://www.youtube.com/watch?v=tO0ClPQ8asg

Covid natural immunity confirmed
Dr. John Campbell
Feb 24, 2023
14 min 49 sec

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis https://www.thelancet.com/journals/la... Group 1 Past SARS-CoV-2 infection Group 2 No past SARS-CoV-2 infection Effectiveness of past infection by outcome Infection Symptomatic disease Severe disease Findings High levels of protection from infection caused by Alpha, beta, and delta variants Lower levels of protection from infection caused by Omicron BA.1 variant Effectiveness against re-infection with the omicron BA.1 variant Protection against reinfection, 45·3% Protection against omicron BA.1 symptomatic reinfection, 44% Protection against severe disease if reinfected with BA.1 is 88.9% Protection from re-infection with ancestral strains Alpha and delta variants Declined over time 78·6% at 40 weeks Protection against re-infection with omicron BA.1 Declined more rapidly 36·1% at 40 weeks Protection against severe disease at 40 weeks if reinfected Remained high for all variants 90·2% for alpha and delta variants 88·9% for omicron BA.1 Data suggests that the level of protection afforded by previous infection is at least as high, if not higher than that provided by two-dose vaccination using high-quality mRNA vaccines As of June 1, 2022 COVID-19 pandemic had caused an estimated 17·2 million total deaths 6·88 million reported deaths 7·63 billion total infections and re-infections. Between 15th November 2021 and 1st June 2022 3·8 billion people 46% of the global population, have been infected by omicron and sublineages. Understanding needed for Predicting future potential disease burden Designing policies, travel, access to venues Informing choices, vaccines Estimate protection from past infection Systematically synthesise studies 65 studies from 19 countries By variant By time since infection Up to Sept 31, 2022

View: https://www.youtube.com/watch?v=U0kGeRJIF6E


Media was complicit with Public Health's Lie about Natural Immunity
Vinay Prasad
Feb 22, 2023
18 min 55 sec

The White House & Public Health lied about natural immunity. A new Lancet paper proves it; I explore how deep the rot goes. Vinay Prasad's Observations and Thoughts | Substack

jward said:

Ray Armat, Ph.D.
@RayArmat
3h

New paper, 2 years late!
Study of 5 million vaccine recipients by Georgia Dept. of Public Health:
"Those with concurrent COVID infection within 21 days post vaccine had an 800% increased risk of ischemic stroke & 523% increased risk of hemorrhagic stroke"

https://twitter.com/i/web/status/1629665329109401601

View: https://twitter.com/RayArmat/status/1629665329109401601?s=20

Click to expand...

This is worth its own thread on my opinion!
A lot of important gets buried in this one.

Heliobas Disciple said:

This explains a lot. Maybe the sudden adult death syndrome has to do with catching covid after the vaccine - the combination. I wonder if an asymptomatic or mild case also causes this, which is why the victim's families didn't put two and two together. ???

HD

Click to expand...

Great point!

I decided to wait until it is at least a peer reviewed article... but yeah- this one brought on a visceral anger I thought we were passed : ((

psychgirl said:

This is worth its own thread on my opinion!
A lot of important gets buried in this one.

Click to expand...

Rita Panahi
@RitaPanahi
27m

‘The U.S. Energy Department has concluded that the Covid pandemic most likely arose from a laboratory leak, according to a classified intelligence report recently provided to the White House and key members of Congress.’

Of course it bloody well did.
View: https://twitter.com/RitaPanahi/status/1629932391702892544?s=20


Never forget the quislings who attacked anybody who suggested the virus came from the Wuhan lab including WaPo’s resident “fact-checker” aka Leftist propagandist.
View: https://twitter.com/RitaPanahi/status/1629938680713580544?s=20